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The containment of potential 
outbreaks triggered by imported 
Chikungunya cases in Italy: a cost 
utility epidemiological assessment 
of vector control measures
F. Trentini  1, P. Poletti1,2, F. Baldacchino3, A. Drago4, F. Montarsi5, G. Capelli5, A. Rizzoli3,  
R. Rosà3, C. Rizzo6, S. Merler2 & A. Melegaro  1,7
The arrival of infected travelers from endemic regions can trigger sustained autochthonous 
transmission of mosquito-borne pathogens in Europe. In 2007 a Chikungunya outbreak was observed 
in central Italy, mostly affecting two villages characterised by a high density of Aedes albopictus. The 
outbreak was mitigated through intervention strategies reducing the mosquito abundance. Ten years 
later, in 2017, sustained Chikungunya transmission was documented in both central and southern Italy. 
The proposed analysis identifies suitable reactive measures for the containment and mitigation of 
future epidemics by combining epidemiological modeling with a health economic approach, considering 
different arrival times of imported infections and possible delays in the notification of cases. Obtained 
estimates suggest that, if the first notification will occur in the middle of the mosquito breeding season, 
the combination of larvicides, adulticides and breeding sites removal represents the optimal strategy. 
In particular, we found that interventions implemented in 2007 were cost-effective, with about 3200 
prevented cases, 1450 DALYs averted and €13.5 M saved. Moreover, larvicides are proven to be more 
cost beneficial in early summer and warmer seasons, while adulticides should be preferred in autumn 
and colder seasons. Our results provide useful indications supporting urgent decision-making of public 
health authorities in response to emerging mosquito-borne epidemics.
Globalisation processes and changes in climatic conditions are progressively increasing the suitability of tem-
perate climate regions for the establishment and diffusion of mosquito species that are competent vectors for the 
transmission of tropical infectious diseases in human populations. This phenomenon combined with an increase 
in human mobility is raising major concerns on the potential diffusion in non-tropical countries of vector-borne 
diseases caused by arboviruses such as Zika, Dengue, West Nile and Chikungunya1,2.
In particular, Chikungunya virus (CHIKV) may represent a major threat for many European countries, as a 
consequence of the high transmissibility potential of this pathogen3–5, and the widespread abundance of Aedes 
albopictus in temperate climate regions, where this mosquito species represents the competent vector for CHIKV 
transmission6,7. CHIKV is characterised by a non-negligible burden of chronic sequelae potentially rising after 
human infection6, and significant costs caused by disease treatment5,8–11. In 2007, Italy was the first European 
country reporting sustained CHIKV transmission, with a major outbreak affecting two municipalities of Emilia 
Romagna and counting more than 200 confirmed cases12. The index case of the observed epidemic was a man 
travelling from Kerala, India, who later tested positive to the virus. Sporadic local transmission events have also 
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been reported in France between 2010 and 201713,14, triggered by the arrival of infected travelers from endemic 
areas. More recently, as of September 18th 2017, two clusters of autochthonous CHIKV transmission were 
detected in the cities of Anzio and Rome, two areas located 60 km apart in the Lazio region in Italy15. Afterwards, 
an additional cluster of transmission was found in the city of Guardavalle Marina in the Calabria region16. The 
Italian authorities immediately launched epidemiological and entomological investigations in the areas and con-
trol strategies were implemented to reduce the mosquito density in the affected areas. The symptom onset for 
the first cases was retrospectively estimated between 26 and 27 June, i.e. three months before the first cluster was 
identified17.
No specific treatment or vaccine is yet available to prevent CHIKV infection and the containment of potential 
future outbreaks mainly relies on the interruption of the transmission chain by means of well-designed preven-
tive and reactive strategies to reduce the mosquitoes density18,19. In the presence of autochthonous transmission, 
public health measures will be likely implemented to interrupt the spread of the infection. However, the arrival 
of imported infected cases from endemic areas seldom triggers large epidemics and may often results in only few 
sporadic cases. In addition, only a fraction of infections shows symptoms and is notified, so that unnoticed trans-
mission may occur. It is therefore essential, when assessing which are the most suitable containment and mitiga-
tion measures, to explicitly account for the risk of observing large outbreaks as a consequence of the importation 
of new cases and also to consider all potential health outcomes and economic costs generated by the different 
intervention policies.
The effectiveness of vector control strategies adopted during the 2007 Italian outbreak20 and of larvicide treat-
ments in areas characterised by low-moderate vector abundance21 has been recently investigated. Cost associated 
with preventive measures adopted in Emilia Romagna after the 2007 outbreak were also quantified22 and the 
impact of CHIKV either in terms of Disability Adjusted Life Years (DALYs) losses10,23 or economic costs was 
evaluated for tropical regions5,10,24. However, only few studies were conducted within a cost-utility framework 
to investigate the cost-effectiveness of vector control strategies. One recent study has focused on the cost-utility 
of routine larvicide applications aimed at preventing Dengue and Chikungunya transmission in temperate cli-
mate regions25. A second one has evaluated preventive measures to reduce the burden of Dengue in an urban 
setting where the disease is endemic, by taking into account insecticide resistance26. Finally, a web-based 
cost-effectiveness tool has been proposed to assess funding commitments required to reduce the burden of Zika 
in the Americas27. However, the assessment of integrated and optimal reactive strategies in response to the noti-
fication of imported cases of vector-borne infections in temperate climate countries still represents an open key 
issue.
The main goal of this work is to evaluate the cost-effectiveness of reactive vector control interventions aimed at 
reducing the potential burden and costs due to CHIKV disease, and to assess whether time of notification of the 
first index case has an impact on the identification of the optimal control strategy. Although the proposed analysis 
was informed with data and information derived from the CHIKV Emilia Romagna outbreak, the outcome of the 
current work is intended to have a broader application and to inform the design of future policy recommenda-
tions to face new potential CHIKV outbreaks in Europe.
Results
Model estimates suggest that, during the 2007 outbreak, if no measure had been taken, the cost of Chikungunya 
cases and their burden in terms of associated morbidity would have been respectively €14.9 M and 1600 DALYs 
lost. The implemented interventions whose costs, around €50000, can be considered negligible with respect to 
the cost of illness, resulted in roughly 3200 (95% CI: 2580–3560) prevented cases, 1450 (95% CI:1,160–1,600) 
DALYs averted, and €13.5 M (95% CI:10.9M–15M) saved for treatment of symptomatic cases, either hospitalised 
or ambulatory patients. In line with estimates provided elsewhere28, the overall cost of the performed intervention 
was found to be, on average, €40 per hectare.
Combining net costs and benefits, and assuming a willingness to pay (WTP) of €30000, the Net Health Benefit 
(NHB) associated with the intervention performed during 2007 was found to be between 1200 and 1600 DALYs 
(Fig. 1). More specifically, our results suggest that whereas the use of larvicides and adulticides both contributed 
significantly to the cost-effectiveness of the implemented vector control program, breeding sites removal had 
a negligible effect on the NHB. The latter indication emerges from the small differences in NHB distribution 
resulting for the integrated vector control program with respect to the one obtained by considering adulticides 
and larvicides only.
The probability distributions associated with (i) different dates of arrival of CHIKV cases from endemic areas, 
and (ii) delays in their notification are shown in Fig. 2a and 2b. In a perfect reporting system, if the index case 
were symptomatic, the time at first notification would coincide with its diagnosis. However, delays in the notifica-
tion of infections could arise as a consequence of both defections in the reporting system and silent transmission 
due to asymptomatic cases. In our model we assume that only 82% of cases are symptomatic and only 54% of 
symptomatic cases are notified29. According to our model, the delay in the notification of the first case is expected 
to be 18.6 days on average, ranging from 2 to 58 days (Fig. 2c). Similarly, the average number of days between 
the observation of the last symptomatic case and the time when the last infected vector dies is estimated to be on 
average 9.1 days, ranging from 0 to 31 days (Fig. 2d). These two quantities are critical for policy decision makers 
as the former provides important information on the onset of an epidemic, and the latter on how long should 
the public healthcare system wait before ceasing interventions after the observation of the last symptomatic case.
The probability of observing autochthonous transmission, as a consequence of the importation of cases, 
increases with mosquito density. Optimal control strategies were therefore investigated by accounting for differ-
ent times at notification of the first case and the uncertainty surrounding possible chains of events affecting the 
CHIKV transmission dynamics and notification. These include for instance the onset of asymptomatic (unno-
ticed) infections and the intrinsic stochasticity characterising the transmission of the pathogen from humans to 
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mosquitoes, and vice-versa. We found that the suitability of interventions, in terms of probability of being the 
most cost-effective strategy, varies broadly with time at notification of the first CHIKV case (Fig. 3a). In par-
ticular our results suggest that, in principle, if a first disease case is notified in the early spring no intervention 
is required. Clearly, this might not be realistically feasible in the presence of an ongoing outbreak. However, it 
is important to stress that, according to our model simulations, in this case the effort required to contain the 
spread of Chikungunya is significantly smaller than the one needed if disease cases are notified between June and 
October. More specifically, we found that larvicides represents the most beneficial intervention in late spring, 
while the combination of larvicides and adulticides alone or with breeding sites removal represents the optimal 
control measure during summer and in early autumn. Interestingly, the application of adulticides alone emerges 
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Figure 1. Posterior distribution of the Net Health Benefit (NHB) for each intervention strategy considered12 
versus the hypothetical scenario where no intervention is implemented, under the assumption that the 
willingness to pay for the healthcare system is €30000. Intervention strategies associated with positive values of 
the NHB should be considered as cost-effective. BS refers to breeding sites removal, LA to larvicides and AD to 
adulticides, while No Int refers to the scenario without any intervention.
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Figure 2. (a) Sampling distribution of dates of arrival of CHIKV cases from endemic area34. (b) Sampling 
distribution of time elapsed between the arrival and the notification of CHIKV cases to public health 
authorities34. (c) Posterior distribution of time elapsed between the arrival of the first case, either symptomatic 
or asymptomatic, and the first notification to public health authorities. (d) Posterior distribution of time elapsed 
between the observation of the last symptomatic case and the last infected vector.
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among the most beneficial strategies when the first case is notified at the end of the mosquito season (which in 
Italy corresponds to late October) proving to be as cost-beneficial as the integrated program.
The impact of single interventions was also evaluated in order to assess which vector control activities should 
be prioritised if autochthonous transmission were observed along the season.
Our results suggest that the cost-effectiveness of the integrated program is mainly driven by larvicide appli-
cations when the first notification occurs between the beginning of June and the end of August (Fig. 3d). On the 
other hand, if a CHIKV case is reported at the beginning of September or later, adulticides prove to be the most 
effective intervention in terms of NHB. Breeding sites removal is instead dominated along the whole season, and 
should be considered only in addition to other strategies. A sensitivity analysis was carried out to investigate the 
robustness of obtained estimates against the uncertainty surrounding the efficacy of vector control activities in 
reducing the mosquito population (see Appendix SI for details). Obtained results show that a lower efficacy of 
single interventions decreased the expected NHB associated with the considered control programs. However, the 
prioritisation of different strategies at different times across the mosquito season remains substantially unchanged 
with respect to results of our baseline analysis. In particular, the adoption of reactive vector control measures 
resulted always cost effective when the notification of a first case occurs between mid June and late October.
However, when considering scenarios associated with colder temperatures (Fig. 3b) model results showed that 
it would be beneficial not to intervene until mid-June, while, later in the season, the use of adulticides emerge as 
the optimal strategy. On the other hand, when assuming higher temperatures (Fig. 3c), reactive interventions are 
required also for notifications occurring earlier, and the best intervention strategy will be represented either by 
the combination of adulticides and larvicides or by the integrated program, combining all vector control activities.
More generally, when looking at the single strategies (Fig. 3e,f), we found that adulticides should be prioritised 
at the very end of the season, no matter what assumption is made on the temperature levels, and in the middle or 
towards the end of the mosquito season in the presence of colder temperatures. On the opposite, warmer tem-
peratures increase the benefits of larvicides, which have a more long lasting impact on the mosquito population 
density. However, if the first notification occurs early in the season, when autochthonous transmission is likely 
to die out soon, the cost effectiveness of adulticides is slightly higher due to their immediate effect on the few 
remaining cases and infected vectors. Further details on the sensitivity analyses are presented in Appendix S1.
Discussion
Autochthonous CHIKV transmission represents a potential threat for temperate climate regions due to the wide-
spread establishment of competent vectors and the constant arrival of travelers who were infected in endemic 
areas. The proposed analysis aims at identifying optimal and cost-effective reactive strategies to reduce the 
risk of large epidemics of tropical vector-borne diseases in those European regions characterised by favorable 
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Figure 3. Top panels show probabilities of being the most cost effective of all possible strategies for different 
times at first notifications when considering temperature records observed during the Italian outbreak in 2007 
(a), with temperatures decreased (b) or increased (c) by 1.5 °C. Bottom panels show probabilities of being 
the most cost effective among the considered single strategies for different times at first notifications with the 
observed temperature records (d), with temperatures decreased (e) or increased (f) by 1.5 °C
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epidemiological and climatic conditions. Our model is specifically tailored to well represent the Ae. albopictus 
vital dynamics and CHIKV transmission in Italy, where this mosquito is the only competent vector for trans-
mission of the infection. This means that suitable control strategies and their relative cost-effectiveness may be 
completely different for other vectors and diseases. In order to extend the proposed analysis to other arboviruses 
(such as Dengue, or Zika) or vectors (as the Ae. aegypti), assumptions made both on the vital dynamic of vectors 
involved, on parameters and mechanisms describing the transmission, and on the associated burden and health 
costs should be all carefully revised2,4,25.
Italy is still by far the most affected European country in terms of Ae. albopictus diffusion on the territory, with 
almost all provinces (97%) reporting the presence of tiger mosquitoes, mainly in the northeastern area between 
Alps and Appennini mountains, and on the cost of the Adriatic Sea30. In particular, Veneto and Emilia Romagna 
report the highest presence with more than 75% of municipalities affected by such vector31. This country has 
experienced two CHIKV outbreaks in the last decade and remains at high risk of future epidemics4,17.
Recent modeling studies, based on robust entomological surveillance data, have highlighted that the highest 
transmissibility potential of arboviruses in temperate climate regions is expected in small-medium size cities 
characterised by a high density of vectors in the human population2,4. This is in agreement with what has been 
observed during the Italian 2007 CHIKV outbreak, which has mainly affected two small municipalities in the 
north-eastern area (Emilia Romagna Region).
As for local transmission events recently reported in central Italy, epidemiological and entomological investi-
gations of separate clusters of Chikungunya cases are currently ongoing. However, it has been suggested that the 
first date of symptoms’ onset of the reported cases was August 5, 2017 and that the first transmission event might 
have taken place around mid-July or before15,17. In agreement with these estimates, we found that the notification 
of cases can occur with an average delay of 19 days after their actual arrival in the area, this being due to problems 
in the reporting system but also the presence of asymptomatic, though infectious, cases. Our results also suggest 
that silent transmission may continue up to two months after the observation of the last symptomatic case and 
this should be taken into consideration when planning the interruption of intervention activities. These results 
are important for planning outbreak investigation activities and monitoring clusters of cases during the final 
phase of an epidemic.
Our results suggest that the combination of vector control activities carried out during the 2007 outbreak 
and targeting different life-stages of the mosquito were the optimal intervention strategy among all the possi-
ble combinations considered, and may have produced about 1450 DALY lost averted and €13.5 M saved. These 
results support the high cost-effectiveness of the performed interventions and quantify their impact both from 
an economic and a health perspective. Cost-effectiveness of different vector control activities, however, varies 
as the notification occurs in different periods of the mosquito season. Specifically, we found that, if a CHIKV 
case is notified during the summer, when mosquitoes density reaches its peak, the combination of larvicide and 
adulticide applications alone or in addition to breeding sites removal were proven to be the optimal intervention 
strategy. Interestingly, by disentangling the contribution of the single interventions, larvicide applications resulted 
more cost-effective between July and August, while our estimates suggest that adulticides should be prioritised 
from September till the end of the mosquito season. On the other side, the contribution of breeding sites removal 
to the effectiveness of a combined intervention was found negligible throughout the whole season. The prioriti-
sation of larvicides during early phases of the mosquito season may derive from the fact that, as suggested in a 
previous work18, larvicides applications are less costly and have longer efficacy. On the opposite, adulticides appli-
cations are more expensive and, although they have an immediate impact on the density of female adults, their 
effects are expected to rapidly wane over time, due to the replenishment of adults from mosquito aquatic stages.
These results should be interpreted in light of the current recommendations on how mosquito control meth-
ods should be integrated into practice for improving of vector management. A recent review of the ECDC32 of 
current international, national and sub-national technical documents, guidance and recommendations on the 
control of invasive mosquitoes suggested that larvicide applications and the removal of Ae. albopictus breeding 
sites are recommended both as preventive measures and in response to an outbreak, while the use of adulti-
cides - when permitted - is recommended only in extreme circumstances. These include the emergence of a new 
Figure 4. Decision tree used to classify simulated CHIKV cases. Transition probabilities to different states of 
the tree are reported in the circles.
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outbreak, but also the identification of significant risk to public health caused by a persistent high density of adult 
mosquitoes32. The importance of investing in vector control measures and their cost-effectiveness in reducing 
the burden of unchecked vector-borne epidemics has been already documented27. However, strategies based on 
continuous larval control have been also suggested to be counterproductive as a consequence of possible insecti-
cide resistance26 and other vector control strategies, such as the use of genetically modified mosquitoes27, may be 
considered in the future as well.
Limitations of the proposed analysis mostly lie on the highly specific epidemiological and climatic conditions 
considered, which has been defined by mimicking temperature records and the mosquito density character-
ising the observed outbreak in Emilia-Romagna during 2007. In addition, our investigation is focused on the 
population and area mirroring the two municipalities mostly affected during the 2007 CHIKV outbreak. These 
conditions should be carefully considered as representative of all temperate climate regions. However, they may 
represent an important illustrative case of favorable climatic and epidemiological scenario for the occurrence of 
potential large epidemics in non-endemic areas. Furthermore, a sensitivity analysis carried out by considering 
alternative temperature patterns reveals that the obtained results in terms of vector control activities that should 
be prioritised during the season may be generalised also to areas with different climatic conditions.
The proposed analysis is based on the simplistic assumption that interventions are carried out along with the 
first notified infection to the public health system, which could be either an imported case or an autochthonous 
one, if the former was not reported. Clearly interventions at the local level may have occurred before the notifi-
cation in the national register, but robust data on this are lacking. Therefore, we adopted a conservative approach 
relying, also, on the available sparse information which suggests this delay to be on average smaller than three 
days.
Strategies implemented after two or more notified infections were not considered in the carried out analysis. 
Nevertheless, our study is restricted to European regions, where we expect a vector control program to be adopted 
as soon as a CHIKV autochthonous transmission is notified to the public health authorities. Finally, the proposed 
analysis focuses on mitigation and containment measures in response to the notification of a CHIKV case so that 
our findings should not be considered to design routine prevention protocols25.
Nonetheless, obtained results give important insights, from a policy-making perspective, on the prioritisation 
of different vector control activities that should be implemented at different time points during the mosquito 
breeding season in response to notifications of imported infectious cases from countries where vector borne 
diseases are endemic.
Methods
Epidemiological model. A stochastic mathematical model is used to mimic the transmission mechanism 
characterising the CHIKV virus, taking into account the seasonal variation in Ae. albopictus abundance within an 
illustrative mosquito season (between April-October), and to simulate the impact of different vector control activ-
ities. The model is the one developed and calibrated in Poletti and coauthors3, here used to evaluate the effects of 
intervention strategies in response to the notification of a CHIKV case returning from an endemic region. Details 
on the model assumptions and on the considered vector control strategies can be found in the Appendix S1.
Model input parameter Value (range) Distribution for PSA Source
Epidemiological parameters – CHIKV
Proportion of symptomatic cases 0.82 (0.7, 0.9) Truncated Normal (0.82, 0.02) 29
Proportion of severe cases 0.07 (0.001, 0.296) Beta (3.69, 48.76) Incidence dataa
Proportion of hospitalisation among severe cases 0.48 (0.26, 0.68) Beta (47.32, 51.5) Incidence dataa
Proportion of hospitalisation among mild cases 0.001 (0.000, 0.01) Beta (0.99, 997.2) Incidence dataa
Proportion of deaths among severe cases 0.001 (0.000, 0.01) Beta (0.99, 999.7) 37
Cost of illness – CHIKV
Length of hospital stay for severe cases (in days) 4.17 (2, 7.9) Gamma (30.86, 0.135) Incidence dataa
Length of hospital stay for mild cases (in days) 3.8 (1.5, 7.1) Gamma (34.18, 0.11) Incidence dataa
Number of ambulatory visits per symptomatic patients 2 Point estimate Expert opinionb
Cost per ambulatory visit (in euro) 47.5 (40, 55) Triangular Expert opinionb
Treatment and test cost for each ambulatory case (in euro) 328.4 (250, 406.8) Triangular Expert opinionb
Treatment and test cost for each hospitalised case (in euro) 1534 0.5 (1400, 1670) Triangular Expert opinionb
Hospital stay cost per day (in euro) 391.7 (370, 413.4) Triangular Expert opinionb
Burden of disease – CHIKV
Duration of illness for each severe cases (in days) 3.2 (0.07, 15.13) Gamma (3.14, 1.02) Incidence dataa
Duration of illness for each mild cases (in days) 2.9 (0.05, 13.75) Gamma (2.58, 1.13) Incidence dataa
Disability weights for each severe case 0.428 (0.38, 0.47) Beta (1047.4, 1399.7) 37
Disability weights for each mild case 0.195 (0.16, 0.24) Beta (305.9, 1262.84) 37
Years life lost in case of death (YLL) 20 (0, 40) Uniform 37
Table 1. Base case values and sampling distributions of cost of illness and DALYs loss parameters. aIncidence 
data were obtained by34. bDepartment of Infectious Diseases of the San Matteo hospital in Pavia, Italy.
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Briefly, the transmission of CHIKV is simulated in a human population of approximately 4,000 individuals, 
mimicking the epidemiological conditions observed during the 2007 Italian outbreak, assuming both air and 
water temperature experienced in that favorable season.
Parameters driving the efficacy of the simulated vector control activities were taken from the original analysis3. 
Breeding sites removal are assumed to reduce by 40% eggs, larvae and pupae, and decrease the carrying capacity 
associated with the aquatic stages by 40% for 30 days. The reduction of larvae and adults through larvicides and 
adulticide applications are respectively assumed to be 90% and 95%. While adulticides are effective within one 
day, the reduction of larvae determined by larvicides is assumed to persist for one month after the intervention 
is carried out. Efficacies of different interventions were assumed according to what reported in the guidelines of 
the European Chemicals Agency (ECHA)33. However we conducted a sensitivity analysis to test the robustness of 
model estimates with respect to possible uncertainty on the assumed efficacy of different vector control activities. 
In this case, we sampled the efficacy of breeding sites removal uniformly between 20–60%, and the efficacy of 
larvicide and adulticide applications between 60–95% (see Appendix S1 for detailed information).
The performed analyses are based on the simulation of different arrival times and notification periods as 
informed with data on the importation of CHIKV cases in Italy over the last 10 years34. These sources of uncer-
tainty, combined with the seasonal variation in vector abundance driven by temperature patterns, result in a vari-
ety of possible outcomes triggered by the importation of an infected human case. In the absence of vector control 
measures, the simulated transmission dynamics can result in: (i) the recovery of the index case with no additional 
human infections; (ii) the occurrence of few sporadic (possibly asymptomatic) cases, caused by autochthonous 
transmission; (iii) a major outbreak affecting a significant proportion of the host population.
In 2007, CHIKV was identified as the pathogen responsible for the Italian outbreak only two months after 
the index case was recorded3,12, while first symptomatic CHIKV cases in 2017 occurred three months before the 
outbreak was detected17. Indeed, only a fraction of CHIKV cases are symptomatic and only a fraction of these 
are notified to public authorities. In particular, it is not unlikely that the first case goes unnoticed and only the 
accumulation of cases leads to the identification of the responsible pathogen. In our simulations, infected cases 
become symptomatic with probability equal to 0.82 and are notified with probability 0.5429 and potential delays in 
the detection of cases are taken into account by considering the distribution of the time lag between the arrival of 
imported cases and their notification to public health authorities34. Finally, in our model, vector control activities 
are assumed to be carried out as soon as the first symptomatic CHIKV case is notified, as required by the National 
Plan of arboviruses surveillance and control35.
Finally, the robustness of model outcomes was assessed for alternative climatic conditions by increasing and 
decreasing temperatures recorded in 2007 by 0.5, 1 and 1.5 °C. Details can be found in the Appendix S1.
Economic model. The effectiveness of the specific intervention strategies was considered with respect to the 
scenario where no intervention was implemented. In order to quantify the disease burden due to CHIKV trans-
mission and the sustained costs, a DALY approach was adopted within a cost-utility framework. DALYs can be 
thought of as a measurement of the gap between individuals’ current health status and an ideal health situation 
where the entire population lives to an advanced age, free of disease and disability. DALY is a function of disability 
weights, duration of the illness and years lost in case of premature death36.
Both DALYs37 and costs were combined with the outputs of the epidemiological model classifying each infec-
tion by means of a decision tree structured according to the probabilities of being symptomatic, severe or mild, 
and of showing different disease outcome including death, hospitalisation or ambulatory assistance (Fig. 4).
Costs of illness were quantified by combining treatment, hospitalisation and ambulatory costs, and the pro-
portion of symptomatic and severe cases among simulated infected individuals. The overall costs of the consid-
ered intervention strategies (i.e. larvicides, adulticides applications and breeding sites removal) were computed 
taking into account also personnel-related expenditures.
DALY losses, cost of illness per case and cost of the different vector control strategies were computed using 
base case parameters values reported in Tables 1 and 2. Details can be found in the Appendix S1.
Intervention parameters
Number of working hours per breeding sites removal on private territory (per ha) 3.04 (1.94, 4.63) Gamma Estimates based on field experience*
Personnel cost per breeding sites removal on private territory (per hour) 15.25 (14.76, 16) Triangular Estimates based on field experience*
Cost of breeding sites removal on public territory (per ha) 9.02 (8, 10) Triangular Estimates based on field experience*
Cost of one larvicide application on public territory (per ha) 3.73 (1.2, 8.4) Triangular Estimates based on field experience* and28
Adulticide cost (per hour) 95 (90, 100) Uniform Estimates based on field experience**
Treated hectares (per hour) 8 (2, 14) Uniform Estimates based on field experience**
Table 2. Base case values and sampling distributions of the costs of interventions. *Vector control activities 
performed during 2015 in the province of Trento and Belluno by the personnel of the Istituto Zooprofilattico 
Sperimentale delle Venezie and the Fondazione Edmund Mach (see Appendix S1 for detailed information). 
**Vector control activities performed during 2015 in the province of Belluno by the personnel of Entostudio.
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The perspective adopted for the economic analysis was that of the Italian public healthcare system. The 
most cost-effective intervention was assessed through the maximisation of the NHB38, defined as the difference 
between the DALYs averted and the incremental cost due to the intervention, the latter divided by the WTP value. 
In order to find highly cost-effective interventions, as suggested by WHO39, we set this value to be approximately 
equal to the Gross Domestic Product (GDP) per capita of Italy in 2007, namely €3000040. A sensitivity analysis on 
the WTP can be found in the Appendix S1.
Probabilistic sensitivity analysis. Possible uncertainties in defining the optimal intervention strategy 
emerge as a consequence of (i) the intrinsic stochasticity of events such as the date at arrival of imported cases, 
the transmission process and the delay in the notification, (ii) the variability characterising model estimates as 
driven by the uncertainty on the epidemiological parameters, (iii) the uncertainty around estimates on costs and 
DALY losses. In order to account for all these factors and to reproduce different epidemiological conditions, we 
performed a probabilistic sensitivity analysis based on the repeated run of model simulations for each considered 
intervention. The proportion of simulations in which a given strategy reached the highest NHB was used to com-
pute the probability of being the most cost-effective. Details on the procedure to assess the optimal strategy in the 
different epidemiological scenarios are provided in the Appendix S1.
Availability of data and material. All data are available as referenced in the article.
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